Catalyst Wire Dossier Catalyst Wire Dossier

MF-4181

· Halscion, Inc.
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for MF-4181, covering 2012-03-13 to 2013-03-29. Get the full timeline:

Most recent: Clinical Trial Update: MF-4181 for the Reduction of Scars Secondary to Abdominoplasty or Laparoscopy/Laparotomy Gynecologic Procedures [Phase 2]

See pricing